Claim Missing Document
Check
Articles

Found 1 Documents
Search

Effectiveness of the Chronic Disease Management Program in Preventing Hypertension Complications at Jala Medika Health Center Andi Asniar Lisa; Najmi Kamariah; Muttaqin
Sahwahita: Community Engagement Journal Vol. 4 No. 1 (2026): Community Engagement Journal
Publisher : Yayasan Pendidikan Islam Bustanul Ulum Mojokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.69965/sahwahita.v4i1.998

Abstract

Hypertension is a chronic condition requiring continuous monitoring, treatment adherence, and lifestyle management to reduce the risk of complications. The Chronic Disease Management Program (Program Pengelolaan Penyakit Kronis/Prolanis) supports continuity of care for people with chronic diseases enrolled in Indonesia’s national health insurance system. This study aimed to analyze Prolanis effectiveness in preventing hypertension complications at Jala Medika Health Center, Makassar, using a results-based approach. A descriptive qualitative design was employed. Sixteen informants were purposively selected: the health center manager, BPJS/P-Care administration officer, Prolanis coordinator, nurses, laboratory personnel, and patients with hypertension. Data were collected through semi-structured in-depth interviews, observation, documentation, and literature review. Credibility was supported through source, method, and time triangulation; analysis followed data reduction, data display, and conclusion drawing. Findings indicate that implementation was supported by program guidance, health personnel, facilities, reported availability of antihypertensive medicines, and routine consultations, health education, exercise, laboratory screening, and home visits. However, P-Care interruptions, staff workload, scheduling conflicts for working-age participants, and inconsistent attendance and medication adherence remained challenges. In 2025, 72 of 97 registered hypertension patients attended second-semester activities (approximately 74%). Administrative records classified 77 patients as having no recorded complications (79.38%) and 20 as having complications (20.62%). Prolanis appears beneficial for patients who participate actively and adhere to treatment, but overall implementation has not reached optimal coverage. The descriptive design does not establish that Prolanis alone caused or prevented these outcomes